Molecular1 microbiologists at the University of Southern California (USC) have uncovered
intricate(复杂的) regulatory
mechanisms3 within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases. Their findings, which have long-standing significance in the basic understanding of cell biology, appear in the journal Nature Cell Biology. "Our research reveals a new regulatory
mechanism2 that
coordinates4 two distinct intracellular processes that are critical to
cellular5 homeostasis(自动调节) and disease development," said Chengyu Liang, M.D., Ph.D., a member of the USC Norris Comprehensive Cancer Center and principal
investigator6 of the study.
The endoplasmic reticulum (
ER内质网) and Golgi
apparatus7 are cellular organelles in eurkaryotic organisms where proteins are synthesized and packaged for
secretion8 through the body. The trafficking of proteins between the ER and Golgi must be tightly
modulated9 to maintain the health of the cell and prevent diseases like cancer from taking hold.
"Interest in the role of ER-Golgi network during cancer cell death has been gaining momentum," said Shanshan He, Ph.D., research associate at the Keck School of Medicine of USC and one of the study's first authors. "In this study, we identified a novel regulatory factor for the Golgi-ER
retrograde(倒退的) transport and a new mechanistic connection between the
physiological10 trafficking and the autophagic transportation of cellular material."
The researchers discovered that the UV irradiation resistance-associated
gene11 protein (UVRAG), which has been
implicated12 in the suppression of
colon13 and breast cancer, coordinates trafficking of proteins between the ER and Golgi apparatus and also
autophagy(自我吞噬), the natural process of breaking down cellular
components14.
"Given that the ER-Golgi network is often
dismantled15 in
malignant16 conditions and that UVRAG is intensively involved in different types of human cancers, this study gives us a new avenue to investigate anti-cancer agents that target UVRAG and/or the ER-Golgi pathway in cancer and other relevant diseases," Liang said.